Back
ProPhase Labs Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
29
PRPH
ProPhase Labs
Last Price:
4.23
Seasonality Move:
6.86%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Sell
29
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy, Sell or Hold?
- The current ProPhase Labs [PRPH] share price is $4.27. The Score for PRPH is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- PRPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRPH Stock Price Chart
What is ProPhase Labs's stock price today?
-
The ProPhase Labs share price today is $4.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 34.39 | Sell |
Chaikin Money Flow: | 1488 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.4 - 5.04) | Sell |
Bollinger Bands (100): | (4.56 - 5.88) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.07 | Buy |
Relative Strength Index (14 RSI): | 68.93 | Buy |
Chaikin Money Flow: | 909555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.85 - 144.93) | Buy |
Bollinger Bands (100): | (118.68 - 136.96) | Buy |
PRPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.37 | Sell |
20-day SMA: | 4.62 | Sell |
50-day SMA: | 4.94 | Sell |
200-day SMA: | 4.93 | Sell |
8-day EMA: | 4.37 | Sell |
20-day EMA: | 4.59 | Sell |
50-day EMA: | 4.9 | Sell |
200-day EMA: | 5.39 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.42 | Buy |
20-day SMA: | 131.3 | Buy |
50-day SMA: | 128.76 | Buy |
200-day SMA: | 115.64 | Buy |
8-day EMA: | 148.13 | Buy |
20-day EMA: | 137 | Buy |
50-day EMA: | 130.51 | Buy |
200-day EMA: | 121.04 | Buy |
ProPhase Labs Earnings Growth & PRPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.18 per share, and an increase next year of $1.40 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
ProPhase Labs Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |